For the quickest way to join, simply enter your email below and get access. We will send a confirmation and sign you up to our newsletter to keep you updated on all your gaming news.
Today, the Path of Exile 2 team unveiled what’s to come in the upcoming 0.5.0 patch. Titled “Return of the Ancients,” this content patch brings the usual campaign and new items—but massive endgame ...
Microsoft open-sourced 86-DOS 1.00 source code on GitHub for its 45th anniversary, according to PCWorld, including kernel and PC-DOS development snapshots. This historically significant software, ...
PC-DOS 1.00 would lead to Microsoft becoming computing's top dog Microsoft continues to embrace open source. The source code and annotations provide insight into the operating system's earliest days.
Claude Opus 4.7 is the latest generally available version of Anthropic’s main AI model with a focus on advanced software development. Opus 4.7 is a notable improvement on Opus 4.6 in advanced software ...
Anthropic on Thursday announced a new artificial intelligence model, Claude Opus 4.7. The company said it is an improvement over past models but is "less broadly capable" than its most powerful ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
Members of the Windows 1.0 team at their 40-year reunion this week. L-R, kneeling/sitting: Joe Barello, Ed Mills, Tandy Trower, Mark Cliggett, Steve Ballmer (holding a Windows 1.0 screenshot) and Don ...
The ending is the main attraction of Tarkov 1.0, finally letting players experience the full story and make their way out of Tarkov in an exciting finale on a new map. Terminal is the final roadblock ...
We are excited to introduce Wan2.2, a major upgrade to our foundational video models. With Wan2.2, we have focused on incorporating the following innovations: 👍 Effective MoE Architecture: Wan2.2 ...
TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study Of 140 patients enrolled, 48.6% had stage IVM1b/c/d disease, ...